Intensive therapy with cisplatin, interleukin-2 and interferon-alpha-2a in patients with metastatic melanoma. A phase II Study.

M. Sznol, R. G. Steis, J. W. Smith, J. E. Janik, W. H. Sharfman, W. J. Urba, R. G. Fenton, S. P. Creekmore, J. Beveridge, D. L. Longo

Research output: Contribution to journalArticle

3 Scopus citations

Fingerprint Dive into the research topics of 'Intensive therapy with cisplatin, interleukin-2 and interferon-alpha-2a in patients with metastatic melanoma. A phase II Study.'. Together they form a unique fingerprint.

Medicine & Life Sciences